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Abstract
Background: The dramatic increase in antibiotic resistance and the recent manifestation in war trauma patients underscore
the threat of Acinetobacter baumannii as a nosocomial pathogen. Despite numerous reports documenting its epidemicity,
little is known about the pathogenicity of A. baumannii. The aim of this study was to obtain insight into the factors that
might explain the clinical success of A. baumannii.
Methodology/Principal Findings: We compared biofilm formation, adherence to and inflammatory cytokine induction by
human cells for a large panel of well-described strains of A. baumannii and compared these features to that of other,
clinically less relevant Acinetobacter species. Results revealed that biofilm formation and adherence to airway epithelial cells
varied widely within the various species, but did not differ among the species. However, airway epithelial cells and cultured
human macrophages produced significantly less inflammatory cytokines upon exposure to A. baumannii strains than to
strains of A. junii, a species infrequently causing infection.
Conclusion/Significance: The induction of a weak inflammatory response may provide a clue to the persistence of A.
baumannii in patients.
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Introduction
With the recent description of Acinetobacter bereziniae (genomic
species (gen. sp.) 10), A. guillouiae (gen. sp. 11) [1], A. venetianus [2]
and A. soli [3], the genus Acinetobacter comprises 23 named species
and 11 species with provisional designations. Of these, A. baumannii
and the closely related A. gen. sp. 3 and 13TU are clinically the
most relevant. Strains of these species have the ability to colonize
and spread among critically ill hospitalized patients. Outbreaks of
multidrug resistant A. baumannii strains have been observed
worldwide [4,5]. A striking manifestation is the dramatic increase
in the frequency of imipenem resistant Acinetobacter isolates in US
hospitals [6] and the recent occurrence of infection in severely
injured soldiers during the conflicts in Iraq and Afghanistan [7].
Three major lineages of genetically highly related A. baumannii
strains, designated European clone I, II and III, have been found
to be frequently implicated in outbreaks [8,9]. Other Acinetobacter
species, such as A. junii, A. johnsonii and A. lwoffii that can frequently
be found on the human skin are only incidentally involved in
infection, which usually has a mild course [4]. This suggests
differences in the pathogenic potential among Acinetobacter species.
The high prevalence of A. baumannii strains in the hospital in
epidemic and endemic situations might be explained by several
factors, including their resistance to antibiotics [10] and
desiccation [11], their ability to form biofilms on medical devices
[12], and to colonize skin and mucosal surfaces of vulnerable hosts
[13,14]. Adherence of bacteria to host cells is generally considered
to be an essential initial step in the colonization process [15]. Once
the primary colonizing bacteria have attached to a surface,
microcolonies are formed after which bacteria may secrete
exopolysaccharides resulting in a highly structured sessile micro-
bial community, the biofilm [16]. Several studies have document-
ed the ability of A. baumannii to adhere to epithelial cells and to
form biofilms on glass and plastic surfaces [12,17,18]. Adherent
bacteria can interact with cells of the host defense systems resulting
in the release of cellular mediators and effector molecules, such as
interleukin (IL)-6 and IL-8 and antimicrobial peptides, which help
to eradicate the pathogen [19].
Little is known about the pathogenicity of A. baumannii.
Moreover, the scarce reports on the virulence of A. baumannii are
focused on one or a few strains only. The purpose of the present
study was to obtain insight into the factors that might explain the
clinical success of A. baumannii. To this aim, biofilm formation was
investigated for a large set of well-described A. baumannii strains
that differed in epidemicity and clonality. Next, biofilm formation
by A. baumannii was compared to that of other Acinetobacter species,
including A. gen. sp. 3 and 13TU, A. calcoaceticus and A. junii. For a
subset of A. baumannii and A. junii strains, adherence to airway
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by these cells and cultured human macrophages was quantitated.
Furthermore, the presence of pilus-like structures that may play a
role in adherence and biofilm formation was assessed with
scanning electron microscopy (SEM).
Results
Biofilm formation
Biofilm formation on plastic at 28uC and 37uC was first
investigated for a comprehensive set of A. baumannii strains. The
results revealed a large variation in biofilm formation among A.
baumannii isolates; the results at 28uC and 37uC did not differ
(Fig. 1). There was no difference in the median biofilm size
between strains from outbreaks (0.9; 0–1.8 a.u.) and those not
assumed to be from outbreaks (0.8; 0.1–2.8 a.u.). Strains of
European clone II (1.1; 0.6–1.8 a.u.) formed larger (p#0.05)
biofilms than strains of clone I (0.8; 0–1.0 a.u.), but not larger than
strains of clone III (1.0; 0.6–1.3 a.u.). Multidrug resistant strains
(0.8; 0–1.8 a.u.) did not form larger biofilms than susceptible
strains (0.8; 0.1–2.8 a.u.). Furthermore, no association between
biofilm formation and body site of isolation was found (data not
shown).
Next, biofilm formation by A. baumannii strains was compared to
that by strains of other Acinetobacter species. No significant
differences in the median size of the biofilms at 28uC were found
between clinically relevant species, i.e., A. baumannii (0.8; 0–2.8
a.u.), A. gen. sp. 3 (1.4; 1.3–1.5 a.u.) and A. gen. sp. 13TU (0.4;
0.2–0.7 a.u.), and the other Acinetobacter species, i.e., A. calcoaceticus
(1.1; 1.0–1.1 a.u.) and A. junii (1.6; 0.5–3.0 a.u.). Similar results
were obtained at 37uC except for strains of A. gen. sp. 13TU that
formed smaller (p#0.05) biofilms than all other species. Of note,
the number of bacteria in the supernatants at the end of each
experiment did not differ much between the different strains (data
not shown).
Adherence to human airway epithelial cells
For further comparison of clinically relevant to less-relevant
Acinetobacter strains and species, experiments exploring the ability of
strains to adhere to and induce cytokines by human cells were
conducted with a subset of strains (further referred to as subset),
including six strains of A. baumannii and six strains of A. junii,a
species infrequently causing infections (Table 1). All selected
strains were epidemiologically unrelated and were genotypically
diverse as assessed by AFLP genomic fingerprinting.
Adherence to human airway epithelial H292 cells varied widely
among the Acinetobacter strains (Table 1). No significant difference
in the percentage of H292 cells associated with bacteria was
observed between A. baumannii (30; 7–55%) and A. junii (23; 11–
70%). In addition, no difference in the number of A. baumannii and
A. junii per positive H292 cell was seen; the median number of
bacteria per H292 cell was 3 (range 1–5). Of note, differences in the
inoculum (within the set range of 7610
6–4610
7) between the
various experiments did not influence the outcome of the
adherence assay. Furthermore, cell monolayers remained intact
and the morphology of the cells was not affected by the bacteria
(data not shown).
Cytokine production by human airway epithelial cells in
response to Acinetobacter
Pilot experiments demonstrated that 1610
8 CFU bacteria
induced higher (p#0.05) levels of the major cytokines IL-6 and
IL-8 in H292 cells than 1610
6 and 1610
7 CFU did. Furthermore,
stimulation with live bacteria resulted in higher (p#0.05) IL-6 and
IL-8 production by H292 cells than heat-inactivated bacteria did.
Time-course experiments demonstrated that the levels of IL-6 and
IL-8 were higher (p#0.05) after 24 h than after 6 h stimulation.
Therefore, further stimulation experiments were performed for
24 h with 1610
8 CFU live bacteria.
Results revealed that H292 cells produced less (p#0.05) IL-8 in
response to A. baumannii strains (1.8; 1.0–3.5 ng/ml) than to A. junii
Figure 1. Biofilm formation by Acinetobacter. Biofilm formation after 24 h at 28uC for the clinically relevant A. baumannii (n=45), A. gen. sp. 3
(n=3) and A. gen. sp. 13TU (n=3) and for the clinically less-relevant A. calcoaceticus (n=3) and A. junii (n=7). Data are expressed as mean biofilm
mass (in arbitrary units (a.u.)) of three independent experiments; each performed in sixplicate. Outbreak-associated (+) or non-outbreak-associated
(2) isolate. European clone I (I), II (II) or III (III) isolate. Multidrug resistant (MDR; +) or susceptible (2) isolate.
doi:10.1371/journal.pone.0010732.g001
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PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10732strains (3.2; 2.1–4.9 ng/ml; Fig. 2). Interleukin-6 production was
lower in response to A. baumannii strains (1.1; 0.6–2.1 ng/ml) than
to strains of A. junii (2.0; 1.4–3.1 ng/ml; Fig. 2), without reaching
statistical significance (p=0.055). Of note, H292 cells stimulated
with cytomix produced 2.3 (0.6–3.0) ng/ml IL-6 and 3.4 (1.4–4.1)
ng/ml IL-8 and unstimulated cells produced 0.1 (0–0.1) ng/ml IL-
6 and 0.2 (0.1–0.2) ng/ml IL-8. Cytokine induction did not vary
widely among strains of each species, except for A. baumannii strain
LUH7312 that induced significantly higher levels of IL-6 and IL-8
than the other A. baumannii strains. Stimulation of H292 cells with 7
additional A. baumannii strains that were epidemiologically
unrelated and genotypically diverse also resulted in low IL-8
(1.3; 0.3–1.7 ng/ml) and IL-6 production (0.1; 0–0.2 ng/ml),
demonstrating that, with the exception of strain LUH7312, A.
baumannii strains induced significantly (p#0.01) less IL-6 and IL-8
than A. junii strains.
Since live bacteria were used in this assay, there was a possibility
of outgrowth that may have caused the difference in cytokine
induction. However, the number of bacteria in the supernatants at
the end of each experiment did not differ much between A.
baumannii and A. junii (range 8610
6–7610
7 CFU/ml). Of note, cell
monolayers remained intact and the morphology of the cells was
not affected by the bacteria (data not shown).
Finally, preliminary experiments demonstrated that exposure of
primary human bronchial epithelial cells of a single donor to six A.
baumannii strains (in triplicate) resulted in lower (p#0.05) levels of
IL-8 (0.9; 0.5–3.6 ng/ml) than to six A. junii strains (4.5; 0.9–
30.7 ng/ml). Cytomix induced 8.6 (7.4–11.5) ng/ml IL-8 in these
cells. Of note, no IL-6 was produced by these primary cells upon
exposure to these two Acinetobacter species or to cytomix.
Cytokine production by cultured human macrophages in
response to Acinetobacter
In tissues, macrophages trigger an adequate innate immune
response upon encountering pathogens. In this regulatory process,
macrophages serve a dual purpose. Initially, they contribute to the
elimination of pathogens and the elicitation of an inflammatory
reaction. When the infection recedes due to removal of the
pathogens, their function may shift toward resolution of inflam-
mation and tissue repair. In line with this notion, we investigated
cytokine production by two clearly distinct types of macrophages,
i.e., pro-inflammatory macrophages (further referred to as type 1
macrophages), and macrophages with an anti-inflammatory/pro-
angiogenic phenotype (type 2 macrophages) [20], upon exposure
to A. baumannii and A. junii strains. Results revealed that
macrophage type 1 produced significantly (p#0.05) less tumor
necrosis factor (TNF)a, IL-12p40, IL-10 and IL-8 in response to
strains of A. baumannii [195 (108–244) ng/ml TNFa, 7 (2–11) ng/
ml IL-12p40, 22 (0–149) pg/ml IL-10 and 49 (27–66) ng/ml IL-8]
than to strains of A. junii [650 (458–812) ng/ml TNFa, 130 (111–
155) ng/ml IL-12p40, 764 (126–1587) pg/ml IL-10 and 111 (48–
208) ng/ml IL-8; Fig. 3]. A. baumannii strains also induced less
(p#0.05) inflammatory cytokines in macrophage type 2 than A.
junii strains (Fig. 3). Of note, cell monolayers remained intact and
the morphology of the cells was not affected by the bacteria (data
not shown).
Electron microscopy analysis of bacterial surface
structures
Pili have been described to be involved in biofilm formation,
adherence and the induction of an immune response [21].
Therefore, we performed SEM to assess the presence of such
surface structures on four A. baumannii strains that differed in their
ability to form biofilm and adhere to human cells. SEM of bacteria
cultured for 16 h at 37uC on blood agar plates revealed two types
of cell appendages: short pilus-like structures and long extensions
(Fig. 4). The latter varied in length, were irregularly distributed
over the cell surface, and sometimes connected bacteria. The
pilus-like structures were detected in A. baumannii strain LUH1398,
a large biofilm former and highly adherent, in LUH7312, a small
biofilm former and highly adherent, and RUH3023
T, a large
biofilm former but poorly adherent (Fig. 4, white arrows). Long
cell extensions were seen in A. baumannii strain RUH3023
T and
RUH3239, a small biofilm former and poorly adherent (Fig. 4,
black arrows). In addition to these structures, there was a marked
surface heterogeneity, from smooth (LUH7312) to pockmarked
Figure 2. Cytokine production by human airway epithelial cells in response to Acinetobacter. Boxplots showing IL-6 and IL-8 production in
ng/ml by H292 airway epithelial cells 24 h after stimulation with strains of A. baumannii (n=6) and A. junii (n=6). Boxes represent medians and second
and third interquartiles, whiskers represent range of 6 strains. *significant (p#0.05) difference between A. baumannii and A. junii.
doi:10.1371/journal.pone.0010732.g002
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T and
RUH3239, strain LUH1398 and LUH7312 formed only a few cell
clusters with no more than four cells grouped together on the glass
slides (data not shown). No difference in structural features was
observed between strains cultured at 37uC and 30uC.
Discussion
This study was undertaken to obtain some insight into the
mechanisms underlying the clinical success of A. baumannii. The
main conclusion from the present study is that strains of A.
baumannii induced a poor inflammatory response in human cells,
despite the finding that they adhered well to these cells. This
conclusion is based on the following findings.
First, airway epithelial H292 cells in vitro produced less IL-6 and
IL-8 in response to A. baumannii strains than to A. junii strains.
Furthermore, cultured human macrophages produced less TNFa,
IL-12p40, IL-8 and IL-10 in response to A. baumannii strains than
to A. junii strains. In agreement with our in vitro data, Qiu et al
documented that the high susceptibility of A/J mice to A. baumannii
ATCC17961 infection was associated with a reduced local pro-
inflammatory response and reduced elimination of bacteria from
the lungs [22]. Knapp et al showed in an in vivo model that A.
baumannii strain RUH2037 induced the release of pro-inflamma-
tory cytokines and chemokines resulting in clearance of bacteria
from the lungs of experimentally infected mice [23]. Although
study-design and outcome were distinct from our study, the
findings emphasize the importance of inflammatory cytokines for
clearing of A. baumannii. It is furthermore of note that our finding
that clinically relevant strains induced a weak immune response in
vitro has also been reported for Haemophilus influenzae [24].
There was a wide variation in biofilm formation among a large
set of well-described A. baumannii strains. Although epidemic
strains did not form larger biofilms than sporadic strains, it
appeared that strains of European clone II formed larger biofilms
than strains of clone I. It is of note that clone II, which was less
frequently involved in outbreaks during the 1990s than clone I, is
now emerging in several European countries with many strains
being carbapenem resistant [25,26]. Further to A. baumannii, the
intra-strain variation in biofilm formation of A. gen. sp. 3 and
13TU and of the clinically less-relevant species A. calcoaceticus and
A. junii was also considerable. Interestingly, there was no difference
between these species, except for A. gen. sp. 13TU that formed
small biofilms.
Many of the strains used for the current biofilm experiments
had previously been used to investigate adherence to H292 airway
epithelial cells [18]. In that study, it was shown that adherence to
airway epithelial cells varied considerably among strains of A.
baumannii, while strains of clone II had higher adherence values
than those of clone I [18]. Likewise, the present study showed a
considerable intra-species variation in adherence to human airway
epithelial cells but no difference between A. baumannii and A. junii
strains. Biofilm formation on plastic was not correlated to
adherence to human cells, indicating that different mechanisms
Figure 3. Cytokine production by human macrophages in response to Acinetobacter. Boxplots showing TNFa (A), IL-12p40 (B), IL-8 (C) and
IL-10 (D) production by cultured human macrophages type 1 (white boxes) and 2 (gray boxes) 24 h after stimulation with strains of A. baumannii
(n=6), A. junii (n=6), LPS and without stimulation (none). Boxes represent medians and second and third interquartiles, whiskers represent range of 6
strains (for A. baumannii and A. junii) or range of experiments with 4 different donors (for LPS and none). *significant (p#0.05) difference between A.
baumannii and A. junii.
doi:10.1371/journal.pone.0010732.g003
Figure 4. Scanning electron micrographs of A. baumannii. Scanning electron micrographs of A. baumannii strain LUH1398, LUH7312, RUH3023,
and RUH3239. Black arrows indicate long cell extensions; white arrows indicate short pili-like structures. Magnification: 30,0006. Bars: 100 nm.
doi:10.1371/journal.pone.0010732.g004
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ability to form biofilm on plastic and the capacity to adhere to
human cells was not always accompanied by the presence of pilus-
like cell surface structures and long cell extensions. Taken
together, it seems that biofilm formation and adherence to human
cells is strain- and not species-specific. Thus, these features do not
solely explain the success of A. baumannii in the susceptible host.
In summary, biofilm formation and adherence to airway
epithelial cells did not differ between clinically relevant and less-
relevant Acinetobacter strains and species. However, there was a
difference in the production of inflammatory cytokines by airway
epithelial cells and macrophages between A. baumannii and A. junii.
This may be a first clue to explain the difference in clinical
behavior between A. baumannii and A. junii. We hypothesize that A.
baumannii may survive and persist in the airways of patients and
cause disease at least in part by inducing a weak inflammatory
response.
Materials and Methods
Bacterial strains, culture conditions and antimicrobial
susceptibility testing
Forty-five A. baumannii,3A. gen. sp. 3, 3 A. gen. sp. 13TU, 3 A.
calcoaceticus, and 7 A. junii isolates, were selected from the Leiden
University Hospital Acinetobacter collection for this study. Of the A.
baumannii strains, 18 were from outbreaks, 16 presumably not from
outbreaks on basis of time-space-origin, and 11 of which the
association with an outbreak was unknown. Eight of the A.
baumannii strains belonged to European clone I, 11 to clone II, and
3 to clone III. All isolates had previously been identified to species
by one or more validated genotypic identification methods
[27,28,29]. Bacteria were preserved for prolonged periods in
nutrient broth supplemented with 20% (vol/vol) glycerol at -80uC.
Prior to each experiment, inocula from frozen cultures were grown
overnight at 30uC [30] on sheep blood agar plates (BioMerieux,
Boxtel, the Netherlands). For experiments, fresh subcultures were
made either under these conditions or in Luria-Bertani (LB)
medium. Susceptibility to antimicrobial agents was determined by
disc diffusion according to CLSI recommendations [31]. Strains
resistant to more than two of the following drug classes were
defined as multidrug resistant: cephalosporins, carbapenems,
ampicillin-sulbactam, quinolones, aminoglycosides.
Biofilm formation
Biofilm formation in 96-wells polyvinylchloride microtiter plates
(Falcon, BD, Breda, the Netherlands) was assayed as described
[32]. Briefly, bacteria from an overnight culture in LB medium
were suspended to 1610
6 CFU/ml as calculated from the
absorbance of a suspension at 600 nm. Five ml of this suspension
was inoculated in 100 ml of M63 medium consisting of KH2PO4
(12 g/l), K2HPO4 (7 g/l), (NH4)2SO4 (2 g/l), glucose (0.2% w/v),
MgSO4 (1 mM) and casaminoacids (0.5% w/v). After 24 h
incubation at 28uC and 37uC, wells were washed and biofilms
attached to the wells were stained with crystal violet (1% w/v). The
optical density at 590 nm, expressed in arbitrary units (a.u.), was
taken as a quantitative measure of biofilm mass. To determine the
bacterial concentration after 24 h, serial dilutions of the
supernatants were made in PBS and plated onto blood agar.
Adherence to human airway epithelial cells
Adherence of bacteria to human bronchial epithelial H292 cells
(ATCC CRL-1848, Manassas, VA, USA) was determined as
described [18]. Briefly, H292 cells were incubated for 1 h at 37uC
with 1610
7 (range 7610
6–4610
7) CFU of an overnight culture on
blood agar. Bacterial adherence to H292 cells was quantified by
light microscopy using two parameters: (i) percentage of epithelial
cells associated with at least one bacterium; and (ii) average
number of bacteria per epithelial cell [18].
Cytokine induction in human airway epithelial cells
Cytokine production by airway epithelial cells in response to
bacteria was determined as described previously [33] with minor
modifications. In short, bacteria were cultured overnight at 30uC
on blood agar and suspended in RPMI-1640 to a concentration
of 5610
8 CFU/ml as assessed spectrophotometrically. Approx-
imately 2610
5 H292 cells were cultured in 0.5 ml of RPMI-1640
supplemented with 2 mM L-glutamine, 50 mg/ml streptomycin,
1000 U sodium penicillin G, and 10% (vol/vol) heat-inactivated
foetal calf serum (FCSi), further referred to as culture medium, in
24-wells plates. At 85–90% confluency, H292 cells were washed
with prewarmed sterile phosphate buffered saline (PBS; pH 7.4)
and incubated at 37uC and 5% CO2 in culture medium without
FCSi for 24 h. Subsequently, cells were washed with prewarmed
PBS and incubated for 1 h at 37uC and 5% CO2 with 1610
6,
1610
7,o r1 610
8 CFU live or heat-inactivated (by 1 h incubation
at 100uC) bacteria. H292 cells were washed five times with
prewarmed PBS to remove non-adherent bacteria and fresh
RPMI-1640 with 2 mM L-glutamine was added. After additional
5 or 23 h incubation at 37uC, supernatants were collected and
stored at 220uC. After 24 h, bacterial CFU count in the
supernatants was determined. In each experiment, RPMI-1640
with 2 mM L-glutamine alone was added to the cells to
determine background values. A mixture of cytokines (100 ng/
ml TNFa, 20 ng/ml IL-1b and 10 ng/ml IFNc; all from
Biosource, Nivelles, Belgium) with 10 ng/ml rough type lipo-
polysaccharide (Escherichia coli J5, Sigma-Aldrich, Zwijndrecht,
the Netherlands), further referred to as cytomix, was added to the
cells as a positive control.
Cytokine induction in cultured human macrophages
Buffy coats from healthy human donors were purchased from
Sanquin bloodbank, Amsterdam, the Netherlands, upon written
consent with regard to scientific use. The current study did not
require approval from an ethics committee according to the Dutch
Medical Research Involving Human Subjects Act. Monocytes
were isolated from buffycoats by Ficoll amidotrizoate density
centrifugation and magnetic sorting using anti-CD14-coated beads
(Miltenyi Biotec, Auburn, CA, USA) according to the manufac-
turer’s instructions. Monocytes were resuspended in culture
medium and cultured at a concentration of 2610
5 cells/ml in
wells of a 24-wells plate at 37uC, 5% CO2 in the presence of either
5 ng/ml recombinant human granulocyte–macrophage colony-
stimulating factor (Biosource International, Camarillo, CA, USA)
to induce differentiation of monocytes into macrophage type 1 or
in the presence of 50 ng/ml recombinant human macrophage
colony-stimulating factor (R&D Systems, Minneapolis, MN, USA)
for type 2 macrophages [20]. After three days, 0.5 ml of fresh
culture medium was added. On the sixth day following isolation,
cells were washed once in PBS and 0.5 ml RPMI-1640 with 2 mM
L-glutamine was added. Bacteria were cultured overnight at 30uC
on blood agar and suspended in PBS to a concentration of
5610
7 CFU/ml as assessed spectrophotometrically. Cells were
stimulated with 1610
7 CFU of live bacteria for 24 h, after which
supernatants were collected and stored at 220uC. In each
experiment, PBS alone was added to the cells to determine
background. Lipopolysaccharide (100 ng/ml, Escherichia coli J5,
Sigma-Aldrich) was added to the cells as a positive control.
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The levels of IL-6, IL-8, TNFa, IL-12p40 and IL-10 in culture
supernatants were determined by ELISA (Biosource) according to
the manufacturer’s instructions. The lower limit of detection was
15 pg/ml for IL-6, 7 pg/ml for IL-8, and 25 pg/ml for TNFa, IL-
12p40 and IL-10.
Electron microscopy analysis of bacterial surface
structures
For SEM, bacteria from an overnight culture on blood agar at
30uC were suspended in PBS and fixed for 1 h at room
temperature with 1.5% (w/v) glutaraldehyde in 0.1 M sodium
cacodylate buffer (1:1). Fixed bacteria were transferred to poly-L-
lysine-coated glass slides. After 1 h incubation at room temper-
ature, bacteria were fixed to the slides with 1.5% glutaraldehyde
for 30 min at room temperature. Thereafter, slides were washed
twice in PBS, dehydrated through a series of graded ethanol,
critical-point-dried, and coated with a layer of palladium-gold.
Bacteria were examined using a JEOL JSM-6700F field emission
scanning electron microscope.
Statistical analysis
Results are expressed as medians and ranges. The Kruskal-
Wallis one-way analysis of variance and the Wilcoxon rank sum
test were used to evaluate differences in distribution. Spearman
rank correlation coefficients were calculated to evaluate possible
associations between epidemicity and adherence to epithelial cells
and biofilm formation on plastic. P values of #0.05 were
considered significant.
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